An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery

<table>(a) Cellular uptake efficiency (%) of Nile red labelled NPs, (b) CsA tear film concentration after administration of a single topical dose to rabbits (<svg height="11.0375" id="M1" style="vertical-align:-0.17555pt" version="1.1" viewbox="0 0 35.099998 11.0375" width="35.099998" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.0375)">
<g transform="translate(72,-63.17)">
<text transform="matrix(1,0,0,-1,-71.95,63.4)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑛</tspan>
<tspan style="font-size: 12.50px; " x="9.6773224" y="0">=</tspan>
<tspan style="font-size: 12.50px; " x="21.71771" y="0">6</tspan>
</text>
</g>
</g>
</svg>) [<a href="/journals/tswj/2012/194848/#B84">8</a>]. (P-CsA = PLGA-CsA, P-E-CsA = PLGA : Eudragit-CsA, P-C-CsA = PLGA-Carbopol-CsA.) </table>

The Scientific World Journal

fig3

Figure 3

Figure 3: An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery 